Zhang Yi, Zhang Xi, Wang Yu, Zhang Jiefeng
Department of Hepatobiliary Surgery, Chongqing Cancer Institute & Hospital & Cancer Center, Chongqing, China.
Surg Laparosc Endosc Percutan Tech. 2017 Oct;27(5):335-340. doi: 10.1097/SLE.0000000000000449.
Clonidine might be beneficial to the patients undergoing laparoscopic cholecystectomy. This meta-analysis focused on the influence of clonidine on hemodynamic responses in patients undergoing laparoscopic cholecystectomy.
We searched several databases including PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases. This meta-analysis included randomized controlled trials regarding the influence of clonidine versus placebo on laparoscopic cholecystectomy. The primary outcomes were mean arterial pressure (MAP) and heart rate (HR) at pneumoperitoneum. The random-effect model was applied for this study.
Compared with control intervention, clonidine intervention was found to significantly reduce the MAP at pneumoperitoneum [standard mean difference=-2.58; 95% confidence interval (CI),-4.63 to -0.53; P=0.01), HR at pneumoperitoneum (standard mean difference=-3.67; 95% CI, -6.57 to -0.76; P=0.01), MAP at intubation (standard mean difference=-2.40; 95% CI, -4.75 to -0.06; P=0.04), HR at intubation (standard mean difference=-3.39; 95% CI, -5.75 to -1.02; P=0.005), propofol requirement (standard mean difference=-2.25; 95% CI, -4.01 to -0.48; P=0.01), as well as postoperative nausea and vomiting (risk ratio, 0.35; 95% CI, 0.19-0.63; P=0.0005).
Compared with control intervention, clonidine intervention was found to significantly reduce MAP and HR at pneumoperitoneum and intubation, propofol requirement, as well as postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
可乐定可能对接受腹腔镜胆囊切除术的患者有益。本荟萃分析聚焦于可乐定对接受腹腔镜胆囊切除术患者血流动力学反应的影响。
我们检索了多个数据库,包括PubMed、EMbase、Web of science、EBSCO和Cochrane图书馆数据库。本荟萃分析纳入了关于可乐定与安慰剂对腹腔镜胆囊切除术影响的随机对照试验。主要结局指标为气腹时的平均动脉压(MAP)和心率(HR)。本研究采用随机效应模型。
与对照干预相比,发现可乐定干预可显著降低气腹时的MAP[标准均差=-2.58;95%置信区间(CI),-4.63至-0.53;P=0.01]、气腹时的HR(标准均差=-3.67;95%CI,-6.57至-0.76;P=0.01)、插管时的MAP(标准均差=-2.40;95%CI,-4.75至-0.06;P=0.04)、插管时的HR(标准均差=-3.39;95%CI,-5.75至-1.02;P=0.005)、丙泊酚需求量(标准均差=-2.25;95%CI,-4.01至-0.48;P=0.01)以及术后恶心呕吐(风险比,0.35;95%CI,0.19 - 0.63;P=0.0005)。
与对照干预相比,发现可乐定干预可显著降低接受腹腔镜胆囊切除术患者气腹和插管时的MAP和HR、丙泊酚需求量以及术后恶心呕吐。